Every recall we track for Nostrum Laboratories, Inc. — 8 in all — plus the complaints and injury reports the public filed about them.
Nostrum Laboratories recalls 100-count and 500-count Sucralfate Tablets (USP 1 gram) due to CGMP deviations causing potential adulteration. Products may not meet quality standards as the company filed for Chapter 11 in September 2024.